FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.464.1003.1050
| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | 2.16.840.1.113883.3.464.1003.1050 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.1050/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1050 |
| Version | 20240123 |
| Status | active |
| Date | 2024-01-23T01:10:32-05:00 |
| Name | PotentiallyHarmfulGastrointestinalAntispasmodicsForOlderAdults |
| Title | Potentially Harmful Gastrointestinal Antispasmodics for Older Adults |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for potentially harmful Gastrointestinal Antispasmodics for older adults as described in the 2023 American Geriatrics Society BEERS criteria.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes atropine, chlordiazepoxide-clidinium, dicyclomine, hyoscyamine, and scopolamine. Includes concepts that represent generic, human use and prescribable medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes ophthalmic routes.) |
Resources that use this resource
No resources found
Resources that this resource uses
Narrative
No narrative content found in resource
Source
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113883.3.464.1003.1050",
"meta": {
"versionId": "16",
"lastUpdated": "2024-01-24T09:18:12.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "NCQA PHEMUR Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-03-10"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2024-01-23"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1050",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.3.464.1003.1050"
}
],
"version": "20240123",
"name": "PotentiallyHarmfulGastrointestinalAntispasmodicsForOlderAdults",
"title": "Potentially Harmful Gastrointestinal Antispasmodics for Older Adults",
"status": "active",
"date": "2024-01-23T01:10:32-05:00",
"publisher": "NCQA PHEMUR",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for potentially harmful Gastrointestinal Antispasmodics for older adults as described in the 2023 American Geriatrics Society BEERS criteria.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes atropine, chlordiazepoxide-clidinium, dicyclomine, hyoscyamine, and scopolamine. Includes concepts that represent generic, human use and prescribable medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes ophthalmic routes.)",
"compose": {
"include": [
{
"valueSet": [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1254"
]
}
]
},
"expansion": {
"identifier": "urn:uuid:5115991b-35e6-46d1-a548-4e73ee66185c",
"timestamp": "2025-05-23T22:13:35-04:00",
"total": 41,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1037234",
"display": "benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1046770",
"display": "12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1046787",
"display": "atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1046815",
"display": "atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1046982",
"display": "hyoscyamine sulfate 0.125 MG Sublingual Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1046985",
"display": "hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1046997",
"display": "atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1047786",
"display": "hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1047881",
"display": "hyoscyamine sulfate 0.025 MG/ML Oral Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1047895",
"display": "hyoscyamine sulfate 0.125 MG/ML Oral Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1047905",
"display": "hyoscyamine sulfate 0.125 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1047916",
"display": "1 ML hyoscyamine sulfate 0.5 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1048124",
"display": "12 HR atropine sulfate 0.04 MG / chlorpheniramine maleate 8 MG / hyoscyamine sulfate 0.19 MG / pseudoephedrine hydrochloride 90 MG / scopolamine hydrobromide 0.01 MG Extended Release Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1048307",
"display": "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1048336",
"display": "hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1050325",
"display": "hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1087365",
"display": "hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1190538",
"display": "0.7 ML atropine sulfate 0.714 MG/ML Auto-Injector"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1190540",
"display": "0.7 ML atropine sulfate 1.43 MG/ML Auto-Injector"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1190542",
"display": "0.7 ML atropine sulfate 2.86 MG/ML Auto-Injector"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1190546",
"display": "10 ML atropine sulfate 0.1 MG/ML Prefilled Syringe"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1190551",
"display": "5 ML atropine sulfate 0.05 MG/ML Prefilled Syringe"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1190552",
"display": "5 ML atropine sulfate 0.1 MG/ML Prefilled Syringe"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1190568",
"display": "atropine sulfate 0.005 MG/ML / diphenoxylate hydrochloride 0.5 MG/ML Oral Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1190572",
"display": "atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1190738",
"display": "atropine sulfate 0.025 MG / difenoxin hydrochloride 1 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1190748",
"display": "5 ML atropine sulfate 0.14 MG/ML / edrophonium chloride 10 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1190776",
"display": "atropine sulfate 0.4 MG/ML Injectable Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1190795",
"display": "1 ML atropine sulfate 1 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1440869",
"display": "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1666781",
"display": "1 ML atropine sulfate 0.4 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1807886",
"display": "Biphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "226552",
"display": "72 HR scopolamine 0.0139 MG/HR Transdermal System"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2637557",
"display": "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "727415",
"display": "2.7 ML atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML Auto-Injector"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "889614",
"display": "chlordiazepoxide hydrochloride 5 MG / clidinium bromide 2.5 MG Oral Capsule"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "991061",
"display": "dicyclomine hydrochloride 10 MG Oral Capsule"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "991065",
"display": "2 ML dicyclomine hydrochloride 10 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "991082",
"display": "dicyclomine hydrochloride 2 MG/ML Oral Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "991086",
"display": "dicyclomine hydrochloride 20 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "998726",
"display": "hyoscyamine sulfate 0.0625 MG / phenyltoloxamine citrate 15 MG Oral Capsule"
}
]
}
}
FHIR